ArticleHuman vaccines & immunotherapeutics2022

Immunogenicity and safety of an investigational quadrivalent meningococcal conjugate vaccine administered as a booster dose in children vaccinated against meningococcal disease 3 years earlier as toddlers: A Phase III, open-label, multi-center study.

Franco M Piazza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.